Synergistic killing in pancreatic cancer cell lines of the combination of a MEK inhibitor and DNA methylation inhibitor.

被引：0
|
作者：
Jeffries, Matlock Arizona
Kurkjian, Carla
机构：
[1] Univ Oklahoma Hlth Sci Ctr, Oklahoma City, OK USA
[2] Stephenson Canc Ctr SCRI, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15025
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The effects of combination treatment of NO-donor and MEK inhibitor on proliferation and invasion of cancer cell lines
    Furuhashi, Satoshi
    Sugita, Hiroki
    Takamori, Hiroshi
    Horino, Kei
    Nakahara, Osamu
    Okabe, Hirohisa
    Abe, Shinya
    Tanaia, Hiroshi
    Beppu, Toru
    Baba, Hideo
    CANCER RESEARCH, 2011, 71
  • [2] Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
    Chavez-Blanco, Alma
    Perez-Plasencia, Carlos
    Perez-Cardenas, Enrique
    Carrasco-Legleu, Claudia
    Rangel-Lopez, Edgar
    Segura-Pacheco, Blanca
    Taja-Chayeb, Lucia
    Trejo-Becerril, Catalina
    Gonzalez-Fierro, Aurora
    Candelaria, Myrna
    Cabrera, Gustavo
    Duenas-Gonzalez, Alfonso
    CANCER CELL INTERNATIONAL, 2006, 6 (1)
  • [3] Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines
    Alma Chavez-Blanco
    Carlos Perez-Plasencia
    Enrique Perez-Cardenas
    Claudia Carrasco-Legleu
    Edgar Rangel-Lopez
    Blanca Segura-Pacheco
    Lucia Taja-Chayeb
    Catalina Trejo-Becerril
    Aurora Gonzalez-Fierro
    Myrna Candelaria
    Gustavo Cabrera
    Alfonso Duenas-Gonzalez
    Cancer Cell International, 6
  • [4] Evaluation of a Combination of an HDAC Inhibitor and a Cell Cycle Inhibitor in Pancreatic Cancer Cells
    Bhutkar, Shraddha P.
    Yadav, Anjali
    Dukhande, Vikas V.
    FASEB JOURNAL, 2022, 36
  • [5] Synergistic effect of MEK inhibitor and metformin combination in low grade serous ovarian cancer
    Mert, Ismail
    Chhina, Jasdeep
    Allo, Ghassan
    Dai, Jing
    Seward, Shelly
    Carey, Mark S.
    Llaurado, Marta
    Giri, Shailendra
    Rattan, Ramandeep
    Munkarah, Adnan R.
    GYNECOLOGIC ONCOLOGY, 2017, 146 (02) : 319 - 326
  • [6] Combination of Gefitinib and DNA Methylation Inhibitor Decitabine Exerts Synergistic Anti-Cancer Activity in Colon Cancer Cells
    Lou, Yun-feng
    Zou, Zheng-zhi
    Chen, Pin-jia
    Huang, Guo-bin
    Li, Bin
    Zheng, De-qing
    Yu, Xiu-rong
    Luo, Xiao-yong
    PLOS ONE, 2014, 9 (05):
  • [7] Mechanistic Investigation of a Combination of a Cell Cycle Inhibitor and an HDAC Inhibitor in Pancreatic Cancer Cells
    Bhutkar, Shraddha
    Yadav, Anjali
    Dukhande, Vikas
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [8] MEK inhibitor enhances the inhibitory effect of imatinib on pancreatic cancer cell growth
    Takayama, Yuichi
    Kokuryo, Toshio
    Yokoyama, Yukihiro
    Nagino, Masato
    Nimura, Yuji
    Senga, Takeshi
    Hamaguchi, Michinari
    CANCER LETTERS, 2008, 264 (02) : 241 - 249
  • [9] The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines
    Shen, Lan
    Li, Ziming
    Shen, Shengping
    Niu, Xiaomin
    Yu, Yongfeng
    Li, Zonghai
    Liao, Meilin
    Chen, Zhiwei
    Lu, Shun
    LUNG CANCER, 2012, 78 (03) : 193 - 200
  • [10] The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma
    Takemoto, Masakazu
    Tanaka, Tomoko
    Tsuji, Ryota
    Togashi, Yuichi
    Higashi, Mayumi
    Fumino, Shigehisa
    Tajiri, Tatsuro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 570 : 41 - 46
12345